133 related articles for article (PubMed ID: 2212115)
1. Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis.
Katayama I; Otoyama K; Kondo S; Nishioka K; Nishiyama S
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):198-201. PubMed ID: 2212115
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies in systemic sclerosis.
Fonollosa V; Selva A; Lima J; Simeon CP; Vilardell M
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):133-4. PubMed ID: 1880247
[No Abstract] [Full Text] [Related]
3. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
[TBL] [Abstract][Full Text] [Related]
4. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.
Malia RG; Greaves M; Rowlands LM; Lawrence AC; Hume A; Rowell NR; Moult J; Holt CM; Lindsey N; Hughes P
Clin Exp Immunol; 1988 Sep; 73(3):456-60. PubMed ID: 2974767
[TBL] [Abstract][Full Text] [Related]
6. Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.
Asherson RA; Tikly M; Staub H; Wilmshurst PT; Coltart DJ; Khamashta M; Hughes GR
Ann Rheum Dis; 1990 Feb; 49(2):107-8. PubMed ID: 2317111
[TBL] [Abstract][Full Text] [Related]
7. Anti-cardiolipin antibodies in progressive systemic sclerosis (PSS).
Bamberga P; Asero R; Vismara A; Brucato A; Riboldi P; Meroni PL
Clin Exp Rheumatol; 1987; 5(4):387-8. PubMed ID: 3440336
[No Abstract] [Full Text] [Related]
8. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.
Harris EN; Asherson RA; Gharavi AE; Morgan SH; Derue G; Hughes GR
Br J Haematol; 1985 Feb; 59(2):227-30. PubMed ID: 3970855
[TBL] [Abstract][Full Text] [Related]
9. [Significance of anticardiolipin antibodies in connective tissue diseases].
Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
[TBL] [Abstract][Full Text] [Related]
10. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunologic features of livedo reticularis in lupus: a case-control study.
Englert HJ; Loizou S; Derue GG; Walport MJ; Hughes GR
Am J Med; 1989 Oct; 87(4):408-10. PubMed ID: 2801732
[TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin antibodies in systemic sclerosis.
Seibold JR; Knight PJ; Peter JB
Arthritis Rheum; 1986 Aug; 29(8):1052-3. PubMed ID: 3741518
[No Abstract] [Full Text] [Related]
13. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus.
Tsutsumi A; Koike T; Ichikawa K; Shimada K; Takabayashi K; Tomioka H; Yoshida S
J Rheumatol; 1988 Dec; 15(12):1764-7. PubMed ID: 3265958
[TBL] [Abstract][Full Text] [Related]
14. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
Cervera R; Font J; López-Soto A; Casals F; Pallarés L; Bové A; Ingelmo M; Urbano-Márquez A
Ann Rheum Dis; 1990 Feb; 49(2):109-13. PubMed ID: 2107799
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin and complement activation: relation to clinical symptoms.
Norberg R; Nived O; Sturfelt G; Unander M; Arfors L
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():149-53. PubMed ID: 3612644
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
Zhou DC; Dong Y; Pan JQ
Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of anticardiolipin antibodies and its significance in systemic lupus erythematosus].
Bao CD; Chen SL; Jiang SJ
Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):74-7, 125. PubMed ID: 2500315
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibodies in rheumatoid arthritis.
Keane A; Woods R; Dowding V; Roden D; Barry C
Br J Rheumatol; 1987 Oct; 26(5):346-50. PubMed ID: 3664159
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus.
Chakravarty KK; Byron MA; Webley M; Durkin CJ; al-Hillawi AH; Bodley R; Wozniak J
Q J Med; 1991 May; 79(289):397-405. PubMed ID: 1924675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
